Listed

Emergent BioSolutions Inc.

EBSNYSECIK 1367644HealthcareFiscal year ends Dec 31

Reports and events: 405 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Emergent BioSolutions Inc., Reports and events
FiledFormWhat it isAccession number
2009-03-1115:52 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001367644-09-000012
2009-03-0600:39 ET10-KAnnual reportPeriod 2008-12-310001367644-09-000009
2009-02-1717:17 ET8-K1.01 Entry into a material agreement0001367644-09-000006
2009-01-2820:23 ET8-K5.02 Departure or appointment of officers or directors0001367644-09-000004
2009-01-1320:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001367644-09-000002

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.